Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma

The necessary precondition for efficient boron neutron capture therapy (BNCT) is control over the content of isotope 10B in the tumor and normal tissues. In the case of boron-containing porphyrins, the fluorescent part of molecule can be used for quantitative assessment of the boron content. Study O...

Full description

Bibliographic Details
Main Authors: Arthur B. Volovetsky, Vladimir S. Sukhov, Irina V. Balalaeva, Varvara V. Dudenkova, Natalia Yu. Shilyagina, Аlexey V. Feofanov, Anastasija V. Efremenko, Mikhail A. Grin, Andrey F. Mironov, Igor B. Sivaev, Vladimir I. Bregadze, Anna V. Maslennikova
Format: Article
Language:English
Published: MDPI AG 2017-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/18/12/2556
id doaj-91bfaeea283c4c8e96e4f0527a045339
record_format Article
spelling doaj-91bfaeea283c4c8e96e4f0527a0453392020-11-25T00:21:26ZengMDPI AGInternational Journal of Molecular Sciences1422-00672017-11-011812255610.3390/ijms18122556ijms18122556Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted CarcinomaArthur B. Volovetsky0Vladimir S. Sukhov1Irina V. Balalaeva2Varvara V. Dudenkova3Natalia Yu. Shilyagina4Аlexey V. Feofanov5Anastasija V. Efremenko6Mikhail A. Grin7Andrey F. Mironov8Igor B. Sivaev9Vladimir I. Bregadze10Anna V. Maslennikova11Department of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, RussiaDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, RussiaDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, RussiaDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, RussiaDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, RussiaShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Str., 117997 Moscow, RussiaShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Str., 117997 Moscow, RussiaInstitute of Fine Chemical Technology, Moscow Technological University, 86 Vernadskii Av., 119571 Moscow, RussiaInstitute of Fine Chemical Technology, Moscow Technological University, 86 Vernadskii Av., 119571 Moscow, RussiaNesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilov Str., 119991 Moscow, RussiaNesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilov Str., 119991 Moscow, RussiaDepartment of Biophysics, Lobachevsky State University of Nizhny Novgorod, 23 Gagarina Av., 603950 Nizhny Novgorod, RussiaThe necessary precondition for efficient boron neutron capture therapy (BNCT) is control over the content of isotope 10B in the tumor and normal tissues. In the case of boron-containing porphyrins, the fluorescent part of molecule can be used for quantitative assessment of the boron content. Study Objective: We performed a study of the biodistribution of the chlorin e6-Cobalt bis(dicarbollide) conjugate in carcinoma-bearing Balb/c mice using ex vivo fluorescence imaging, and developed a mathematical model describing boron accumulation and release based on the obtained experimental data. Materials and Methods: The study was performed on Balb/c tumor-bearing mice (CT-26 tumor model). A solution of the chlorin e6-Cobalt bis(dicarbollide) conjugate (CCDC) was injected into the blood at a dose of 10 mg/kg of the animal’s weight. Analysis of the fluorescence signal intensity was performed at several time points by spectrofluorimetry in blood and by laser scanning microscopy in muscle, liver, and tumor tissues. The boron content in the same samples was determined by mass spectroscopy with inductively coupled plasma. Results: Analysis of a linear approximation between the fluorescence intensity and boron content in the tissues demonstrated a satisfactory value of approximation reliability with a Spearman’s rank correlation coefficient of r = 0.938, p < 0.01. The dynamics of the boron concentration change in various organs, calculated on the basis of the fluorescence intensity, enabled the development of a model describing the accumulation of the studied compound and its distribution in tissues. The obtained results reveal a high level of correspondence between the model and experimental data.https://www.mdpi.com/1422-0067/18/12/2556boron neutron capture therapyfluorescent microscopyboron contentMS-ICPsimple multichamber modelchlorin e6 derivatives
collection DOAJ
language English
format Article
sources DOAJ
author Arthur B. Volovetsky
Vladimir S. Sukhov
Irina V. Balalaeva
Varvara V. Dudenkova
Natalia Yu. Shilyagina
Аlexey V. Feofanov
Anastasija V. Efremenko
Mikhail A. Grin
Andrey F. Mironov
Igor B. Sivaev
Vladimir I. Bregadze
Anna V. Maslennikova
spellingShingle Arthur B. Volovetsky
Vladimir S. Sukhov
Irina V. Balalaeva
Varvara V. Dudenkova
Natalia Yu. Shilyagina
Аlexey V. Feofanov
Anastasija V. Efremenko
Mikhail A. Grin
Andrey F. Mironov
Igor B. Sivaev
Vladimir I. Bregadze
Anna V. Maslennikova
Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma
International Journal of Molecular Sciences
boron neutron capture therapy
fluorescent microscopy
boron content
MS-ICP
simple multichamber model
chlorin e6 derivatives
author_facet Arthur B. Volovetsky
Vladimir S. Sukhov
Irina V. Balalaeva
Varvara V. Dudenkova
Natalia Yu. Shilyagina
Аlexey V. Feofanov
Anastasija V. Efremenko
Mikhail A. Grin
Andrey F. Mironov
Igor B. Sivaev
Vladimir I. Bregadze
Anna V. Maslennikova
author_sort Arthur B. Volovetsky
title Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma
title_short Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma
title_full Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma
title_fullStr Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma
title_full_unstemmed Pharmacokinetics of Chlorin e6-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma
title_sort pharmacokinetics of chlorin e6-cobalt bis(dicarbollide) conjugate in balb/c mice with engrafted carcinoma
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2017-11-01
description The necessary precondition for efficient boron neutron capture therapy (BNCT) is control over the content of isotope 10B in the tumor and normal tissues. In the case of boron-containing porphyrins, the fluorescent part of molecule can be used for quantitative assessment of the boron content. Study Objective: We performed a study of the biodistribution of the chlorin e6-Cobalt bis(dicarbollide) conjugate in carcinoma-bearing Balb/c mice using ex vivo fluorescence imaging, and developed a mathematical model describing boron accumulation and release based on the obtained experimental data. Materials and Methods: The study was performed on Balb/c tumor-bearing mice (CT-26 tumor model). A solution of the chlorin e6-Cobalt bis(dicarbollide) conjugate (CCDC) was injected into the blood at a dose of 10 mg/kg of the animal’s weight. Analysis of the fluorescence signal intensity was performed at several time points by spectrofluorimetry in blood and by laser scanning microscopy in muscle, liver, and tumor tissues. The boron content in the same samples was determined by mass spectroscopy with inductively coupled plasma. Results: Analysis of a linear approximation between the fluorescence intensity and boron content in the tissues demonstrated a satisfactory value of approximation reliability with a Spearman’s rank correlation coefficient of r = 0.938, p < 0.01. The dynamics of the boron concentration change in various organs, calculated on the basis of the fluorescence intensity, enabled the development of a model describing the accumulation of the studied compound and its distribution in tissues. The obtained results reveal a high level of correspondence between the model and experimental data.
topic boron neutron capture therapy
fluorescent microscopy
boron content
MS-ICP
simple multichamber model
chlorin e6 derivatives
url https://www.mdpi.com/1422-0067/18/12/2556
work_keys_str_mv AT arthurbvolovetsky pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT vladimirssukhov pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT irinavbalalaeva pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT varvaravdudenkova pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT nataliayushilyagina pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT alexeyvfeofanov pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT anastasijavefremenko pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT mikhailagrin pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT andreyfmironov pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT igorbsivaev pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT vladimiribregadze pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
AT annavmaslennikova pharmacokineticsofchlorine6cobaltbisdicarbollideconjugateinbalbcmicewithengraftedcarcinoma
_version_ 1725362681411534848